Traduction de «treatment of major depression with nortriptyline » (Néerlandais → Français) :

17. Nelson JC, Kennedy JS, Pollock BG, Laghrissi-Thode F, Narayan M, Nobler MS et al. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease.
17. Nelson JC, Kennedy JS, Pollock BG, Laghrissi-Thode F, Narayan M, Nobler MS et al. Treatment of major depression with Nortriptyline and paroxetine in patients with ischemic heart disease.

AGO178 (agomelatine), a once-daily investigational treatment for patients with major depression, will be studied in additional Phase III trials to further explore the benefit/risk and pharmacokinetic profile of this compound.
AGO178 (agomélatine), un traitement investigationnel par prise unique quotidienne contre la dépression sévère, fera l’objet d’une étude dans le cadre d’essais supplémentaires de phase III afin d’explorer plus avant le profil bénéfice/risque et pharmacocinétique de cette molécule.

The difference with the DSM-IV is that the ICD-10 offers a series of independent criteria for each level of severity (mild, moderate, severe) of a major depressive episode.
La différence avec le DSM-IV est que la CIM-10 propose une série de critères indépendants pour chaque degré de sévérité (léger, moyen, sévère) d’un épisode dépressif majeur.

Its symptoms are less severe than those associated with major depressive disorders.
Les symptômes y sont moins sévères que ceux du trouble dépressif majeur.

18. Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT, Jr., Pollock BG et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
18. Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT, Jr., Pollock BG et al. Comparison of paroxetine and Nortriptyline in depressed patients with ischemic heart disease.

SANDERS MR, MCFARLAND M. Treatment of depressed mothers with disruptive children: A controlled evaluation of cognitive behavioural family intervention.
Anxiety disorders in children and adolescents: Research, assessment and intervention.

Among other things, the EAAD seeks to promote the relevant knowledge and understanding by providing the target groups with correct and adequate information on the symptoms, the causes and possible treatment of depression and suicidality.
L’EAAD veut entre autre stimuler les connaissances et la compréhension en diffusant de l’information correcte et adaptée aux groupes cibles sur les symptômes, les causes et les possibilités de traitement de la dépression et la suicidalité.

Li M, Fitzgerald P, Rodin G. Evidence-based treatment of depression in patients with cancer.
DOI: 10.1002/14651858.CD004596. Traeger L, Greer JA, Fernandez-Robles C et al. Evidence-based treatment of anxiety in patients with cancer.